Mukka Proteins Stock Screener | Share Price & Fundamental Analysis
MUKKA
Animal Feed
Screen Mukka Proteins share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹23.81
▼
-0.24 (-1.00%)
Share Price BSE
₹23.82
▼
-0.19 (-0.79%)
Market Cap
₹721.50 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
1.63
EPS (TTM)
₹1.55
Dividend Yield
-
Debt to Equity
0.98
52W High
₹38.55
52W Low
₹23.81
Operating Margin
5.00%
Profit Margin
2.89%
Revenue (TTM)
₹242.00
EBITDA
₹18.00
Net Income
₹7.00
Total Assets
₹1,076.00
Total Equity
₹457.00
Mukka Proteins Share Price History - Stock Screener Chart
Screen MUKKA historical share price movements with interactive charts. Analyze price trends and patterns.
Mukka Proteins Company Profile - Fundamental Screener
Screen Mukka Proteins company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for MUKKA shares.
Sector
Food Products
Industry
Animal Feed
Sub-Sector
Animal Feed
Segment
E
ISIN
INE0CG401037
Mukka Proteins Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen MUKKA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Total Assets | 1,076 | 941 | 575 | 392 | 355 | 293 | 201 |
| Current Assets | 926 | 817 | 464 | 286 | 257 | 206 | 142 |
| Fixed Assets | 94 | 85 | 85 | 83 | 79 | 78 | 49 |
| Liabilities | |||||||
| Total Liabilities | 1,076 | 941 | 575 | 392 | 355 | 293 | 201 |
| Current Liabilities | 9 | 12 | 17 | 15 | 13 | 18 | 20 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||||
| Total Equity | 457 | 408 | 156 | 103 | 70 | 58 | 44 |
| Share Capital | 30 | 30 | 22 | 22 | 6 | 6 | 6 |
| Reserves & Surplus | 411 | 366 | 126 | 76 | 61 | 51 | 39 |
Screen MUKKA income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 242 | 167 | 376 | 303 | 149 | 170 | 255 | 510 | 331 | 269 | 409 | 397 |
| Expenses | 224 | 157 | 353 | 262 | 140 | 159 | 225 | 498 | 294 | 260 | 378 | 362 |
| EBITDA | 18 | 11 | 24 | 41 | 9 | 11 | 30 | 12 | 37 | 9 | 31 | 34 |
| Operating Profit % | 5.00% | 5.00% | 5.00% | 12.00% | 4.00% | 5.00% | 10.00% | 1.00% | 9.00% | 2.00% | 8.00% | 8.00% |
| Depreciation | 4 | 3 | 3 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Interest | 13 | 11 | 10 | 11 | 9 | 8 | 7 | 6 | 6 | 6 | 7 | 4 |
| Profit Before Tax | 9 | 2 | 20 | 33 | 1 | 6 | 27 | 18 | 35 | 8 | 33 | 33 |
| Tax | 2 | 1 | 6 | 6 | 0 | 0 | -2 | 5 | 6 | 4 | 11 | 6 |
| Net Profit | 7 | 2 | 14 | 27 | 2 | 5 | 29 | 12 | 29 | 4 | 22 | 27 |
| EPS | 0.20 | 0.05 | 0.45 | 0.88 | 0.07 | 0.14 | 1.20 | 0.48 | 1.29 | 0.16 | 0.99 | 1.03 |
Mukka Proteins Cash Flow Screener - Liquidity Fundamentals
Screen MUKKA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March |
|---|---|---|---|---|---|---|---|
| Operating Activities | -112 | -150 | -56 | 5 | 2 | -25 | -20 |
| Investing Activities | -35 | -48 | -3 | -12 | -14 | -28 | -23 |
| Financing Activities | 56 | 266 | 75 | 15 | 14 | 54 | 34 |
| Net Cash Flow | -91 | 68 | 15 | 8 | 2 | 1 | -9 |
Screen MUKKA shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Feb | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 73.33% | 73.33% | 73.33% | 100.00% | 73.33% | 73.33% | 73.33% | 73.33% |
| FII Holding | 2.63% | 2.08% | 1.70% | 0.00% | 6.46% | 5.08% | 2.82% | 2.63% |
| DII Holding | 1.98% | 1.87% | 1.66% | 0.00% | 2.00% | 2.50% | 2.00% | 1.98% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 19.85% | 21.55% | 22.18% | 0.00% | 17.38% | 17.54% | 19.32% | 19.43% |
| Other Holding | 2.21% | 1.15% | 1.13% | 0.00% | 0.83% | 1.56% | 2.53% | 2.62% |
| Shareholder Count | 147,308 | 145,343 | 141,649 | 8 | 54,061 | 112,093 | 144,549 | 146,062 |
Mukka Proteins Dividend Screener - Share Yield Analysis
Screen MUKKA dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Mukka Proteins Index Membership - Market Screener Classification
Screen MUKKA by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Mukka Proteins Market Events Screener - Corporate Actions
Screen MUKKA market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -0.47% | ||
| Annual General Meeting | NA | -14.11% | ||
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | -3.56% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | 0.37% |
| 2025-05-15 | 2025-05-15 | Quarterly Result Announcement | NA | 3.72% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | -7.44% |
| 2024-11-16 | 2024-11-16 | Extraordinary General Meeting | NA | -1.05% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -11.75% |
Mukka Proteins Competitors Screener - Peer Comparison
Screen MUKKA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Avanti Feeds | 11,993 | 18.35 | 5,778 | 4.95% | 557 | 65.37 |
| Godrej Agrovet | 11,039 | 26.70 | 9,426 | -1.83% | 403 | 45.88 |
| KSE | 736 | 5.58 | 1,658 | -1.77% | 91 | 51.37 |
| Mukka Proteins | 722 | 14.68 | 1,022 | -26.83% | 48 | 42.79 |
| Shivam Chemicals | 104 | 49.60 | 226 | 53.57% | 2 | 8.22 |
| Mayank Cattle Food | 91 | 17.99 | 393 | % | 5 | 11.22 |
| Narmada Agrobase | 85 | 21.69 | 66 | 31.55% | 4 | 55.94 |
Mukka Proteins Company Announcements - News Screener
Screen MUKKA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-04 | Announcement under Regulation 30 (LODR)-Updates on Acquisition | View |
| 2026-01-04 | Announcement under Regulation 30 (LODR)-Updates on Acquisition | View |
| 2026-01-03 | Receipt Of Bond Enforcement Order From Office Of The Commissioner Of Customs. | View |
| 2026-01-03 | Closure of Trading Window | View |
| 2025-12-31 | Announcement under Regulation 30 (LODR)-Updates on Acquisition | View |
| 2025-12-19 | Update On Litigation. | View |
| 2025-12-16 | Announcement under Regulation 30 (LODR)-Acquisition | View |
| 2025-12-10 | Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements | View |
| 2025-12-06 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-12-06 | Intimation Of CIN Change. | View |
| 2025-12-03 | Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order | View |
| 2025-12-02 | Intimation Of Appointment Of IRA. | View |
| 2025-11-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-13 | Renewal Of Consent For Operation (CFO-Air Water) For The Subsidiary Comapny And Group Companies. | View |
| 2025-11-12 | Announcement under Regulation 30 (LODR)-Acquisition | View |
| 2025-11-12 | Board Meeting Outcome for Financial Results For The Quarter And Half Year Ended 30Th September 2025. | View |
| 2025-11-12 | Financial Results For The Quarter And Half Year Ended 30Th September 2025. | View |
| 2025-11-06 | Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2025. | View |
| 2025-11-01 | Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015. | View |
| 2025-10-17 | Intimation Regarding Change Of Corporate Identification Number (CIN) Of Mukka Proteins Limited (The Company). | View |